Quick Answer
Neumora Therapeutics, Inc. reported Total Assets of $191.05 million for the year ending 2025.
- Neumora Therapeutics, Inc. showed a decrease of -39.7% in Total Assets from 2024 to 2025.
- This data is from Neumora Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $544.75 million | Q1 2024: $450.21 million | Q2 2024: $404.47 million | Q3 2024: $352.54 million | Q1 2025: $256.75 million | Q2 2025: $223.83 million | Q3 2025: $177.83 million.
- Over the full 4 years of available data (2022 to 2025), Neumora Therapeutics, Inc.'s Total Assets has declined by 55.2%.
- Historical annual values: Fiscal year 2025: $191.05 million | Fiscal year 2024: $316.97 million | Fiscal year 2023: $496.20 million | Fiscal year 2022: $426.23 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: